# Buprenorphine and Integrated HIV Care

> **NCT00317460** · PHASE4 · COMPLETED · sponsor: **Yale University** · enrollment: 52 (actual)

## Conditions studied

- Substance-related Disorders
- Drug Addiction
- Human Immunodeficiency Virus
- AIDS
- HIV Infections

## Interventions

- **OTHER:** Physician Management
- **BEHAVIORAL:** Counseling

## Key facts

- **NCT ID:** NCT00317460
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2009-10
- **Final completion:** 2012-10
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2020-04-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00317460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00317460, "Buprenorphine and Integrated HIV Care". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00317460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*